Works matching IS 03065251 AND DT 2020 AND VI 86 AND IP 9
Results: 26
Opportunities for using in silico‐based extended dosing regimens for monoclonal antibody immune checkpoint inhibitors.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1769, doi. 10.1111/bcp.14369
- By:
- Publication type:
- Article
Issue Highlights.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1671, doi. 10.1111/bcp.14520
- Publication type:
- Article
Correction.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1894, doi. 10.1111/bcp.14497
- Publication type:
- Article
Taking the brake off the immune system: Hypotheses, trials, tribulations, and the evolving discipline of clinical immunopharmacology.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1674, doi. 10.1111/bcp.14481
- By:
- Publication type:
- Article
Evolving insights into the mechanisms of toxicity associated with immune checkpoint inhibitor therapy.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1778, doi. 10.1111/bcp.14433
- By:
- Publication type:
- Article
Novel strategies in immune checkpoint inhibitor drug development: How far are we from the paradigm shift?
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1753, doi. 10.1111/bcp.14355
- By:
- Publication type:
- Article
Chronic myeloid leukaemia and the use of tyrosine kinase inhibitors in the days of COVID‐19 pandemic.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1790, doi. 10.1111/bcp.14353
- By:
- Publication type:
- Article
Immune checkpoint blockade in solid organ tumours: Choice, dose and predictors of response.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1736, doi. 10.1111/bcp.14352
- By:
- Publication type:
- Article
Radiation therapy and the innate immune response: Clinical implications for immunotherapy approaches.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1726, doi. 10.1111/bcp.14351
- By:
- Publication type:
- Article
Why we need to pay attention to toxicity associated with herbal medicines.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1793, doi. 10.1111/bcp.14340
- By:
- Publication type:
- Article
Scientifically based combination therapies with immuno‐oncology checkpoint inhibitors.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1711, doi. 10.1111/bcp.14338
- By:
- Publication type:
- Article
Cost‐effectiveness and financial risks associated with immune checkpoint inhibitor therapy.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1703, doi. 10.1111/bcp.14337
- By:
- Publication type:
- Article
Protective effects of doxepin cream on radiation dermatitis in breast cancer: A single arm double‐blind randomized clinical trial.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1875, doi. 10.1111/bcp.14238
- By:
- Publication type:
- Article
Expanded Access as a source of real‐world data: An overview of FDA and EMA approvals.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1819, doi. 10.1111/bcp.14284
- By:
- Publication type:
- Article
Mechanism‐based treatment of cancer with immune checkpoint inhibitor therapies.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1690, doi. 10.1111/bcp.14316
- By:
- Publication type:
- Article
Safety, pharmacokinetics and pharmacodynamics of branebrutinib (BMS‐986195), a covalent, irreversible inhibitor of Bruton's tyrosine kinase: Randomised phase I, placebo‐controlled trial in healthy participants.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1849, doi. 10.1111/bcp.14290
- By:
- Publication type:
- Article
Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1836, doi. 10.1111/bcp.14289
- By:
- Publication type:
- Article
Association between 8 P‐glycoprotein (MDR1/ABCB1) gene polymorphisms and antipsychotic drug‐induced hyperprolactinaemia.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1827, doi. 10.1111/bcp.14288
- By:
- Publication type:
- Article
Impacts of CYP2C19 genetic polymorphisms on bioavailability and effect on platelet adhesion of vicagrel, a novel thienopyridine P2Y<sub>12</sub> inhibitor.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1860, doi. 10.1111/bcp.14296
- By:
- Publication type:
- Article
Unexpected overdose blood concentration of tacrolimus: Keep in mind the role of inflammation.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1888, doi. 10.1111/bcp.14292
- By:
- Publication type:
- Article
Chimeric antigen receptor T‐cell therapies: Optimising the dose.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1678, doi. 10.1111/bcp.14281
- By:
- Publication type:
- Article
Exposure–response characterisation of tildrakizumab in chronic plaque psoriasis: Pooled analysis of 3 randomised controlled trials.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1795, doi. 10.1111/bcp.14280
- By:
- Publication type:
- Article
Patterns of pregabalin initiation and discontinuation after its subsidy in Australia.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1882, doi. 10.1111/bcp.14276
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1669, doi. 10.1111/bcp.14011
- Publication type:
- Article
Pharmacokinetics and safety of olaparib in patients with advanced solid tumours and mild or moderate hepatic impairment.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1807, doi. 10.1111/bcp.14283
- By:
- Publication type:
- Article
Pharmacokinetic herb‐drug interaction between ginger and crizotinib.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1892, doi. 10.1111/bcp.13862
- By:
- Publication type:
- Article